Related Experiment Video
Updated: Jun 2, 2026
07:03
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts
Virginie Vives1, Mélanie Laurin, Gaelle Cres
1Montpellier Universities 1 and 2, CRBM, Montpellier, France.
Summary
Dock5 is essential for osteoclast function and bone resorption. Inhibiting Dock5 may offer a new strategy for treating osteoporosis by reducing excessive bone loss.
Area of Science:
- Cell Biology
- Bone Biology
- Pharmacology
Background:
- Osteoporosis is a major health concern in the elderly, characterized by excessive bone resorption by osteoclasts.
- Osteoclast function, particularly the formation of the sealing zone essential for bone resorption, relies on actin cytoskeleton regulation by Rho GTPases.
- Identifying key regulators of osteoclast activity is crucial for developing novel therapeutic strategies against osteoporosis.
Purpose of the Study:
- To investigate the role of the atypical Rac1 exchange factor Dock5 in osteoclast function and bone resorption.
- To determine if Dock5 is a potential therapeutic target for anti-osteoporotic treatments.
Main Methods:
- In vitro studies of osteoclast sealing zone formation and resorbing activity in the presence or absence of Dock5.
- Analysis of osteoclast adhesion, Rac1, and p130Cas activities.
- In vivo studies using Dock5 knockout mice (Dock5(-/-)) to assess trabecular bone mass and osteoclast numbers.
- Identification and testing of a novel small-molecule inhibitor of Dock5.
Main Results:
- Dock5 is required for the establishment of the sealing zone and osteoclast resorbing activity in vitro.
- Osteoclasts lacking Dock5 exhibit impaired adhesion due to perturbed Rac1 and p130Cas activities.
- A novel small-molecule inhibitor of Dock5 effectively reduced osteoclast resorbing activity.
- Dock5(-/-) mice display increased trabecular bone mass with normal osteoclast numbers, indicating Dock5's essential role in bone resorption but not osteoclast differentiation.
Conclusions:
- Dock5 is a critical regulator of osteoclast function, specifically mediating adhesion and bone resorption.
- Dock5 is essential for osteoclast resorbing activity in vitro and in vivo.
- Targeting Dock5 with small-molecule inhibitors presents a promising therapeutic approach for developing novel anti-osteoporotic treatments.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:18The Bone Matrix
Bone contains a relatively small number of cells entrenched in a matrix of collagen fibers that provide an adherent surface for inorganic salt crystals. Both components of the matrix, organic and inorganic, contribute to the unusual properties of bone. Without collagen, bones would be brittle and shatter easily. Without mineral crystals, bones would flex and provide little support. This can be observed by an experiment: when the minerals of a bone are dissolved by soaking the bone in acid or...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.